Company No:
Contents
Note | 31.12.2024 | |
£ | ||
Fixed assets | ||
Investments | 3 |
|
2,234,649 | ||
Creditors: amounts falling due within one year | 4 | (
|
Net current liabilities | (100) | |
Total assets less current liabilities | 2,234,549 | |
Net assets |
|
|
Capital and reserves | ||
Called-up share capital | 5 |
|
Share premium account |
|
|
Profit and loss account |
|
|
Total shareholders' funds |
|
Directors' responsibilities:
These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of Sangfroid Holdings Ltd (registered number:
H M B Hayes
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.
Sangfroid Holdings Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is The Generator Hub Kings Wharf, The Quay, Exeter, EX2 4AN, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
Group accounts exemption s399
The Company has taken advantage of the exemption in section 399 of the Companies Act 2006 not to prepare consolidated accounts, because the group it heads qualifies as small. The financial statements present information about the Company as an individual entity only.
The company shortened the year end to 31 December 2024 from 31 August 2025 to be coterminous with other related companies.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.
Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.
Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.
Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.
Other basic financial liabilities are measured at amortised cost.
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.
Period from 09.08.2024 to 31.12.2024 |
|
Number | |
Monthly average number of persons employed by the Company during the period, including directors |
|
Investments in subsidiaries
31.12.2024 | |
£ | |
Cost | |
At 09 August 2024 | 0 |
Additions |
|
At 31 December 2024 |
|
Carrying value at 31 December 2024 |
|
31.12.2024 | |
£ | |
Amounts owed to Group undertakings |
|
31.12.2024 | |
£ | |
Allotted, called-up and fully-paid | |
|
|
|
|
|
|
|
|
200 |
Transactions with entities in which the entity itself has a participating interest
31.12.2024 | |
£ | |
Sangfroid Group Limited | 100 |
During the period Sangfroid Holdings Limited loaned Sangfroid Group Limited £100. No interest has been charged and the amount is repayable on demand.